

Most Read This Week
- Palbociclib in Combination With Endocrine Therapy vs Capecitabine in HR-Positive, HER2-Negative, Aromatase Inhibitor–Resistant Metastatic Breast Cancer
- Laparoscopic vs Open Gastrectomy for Gastric Cancer
- Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer
- Key Takeaways in Bleeding Disorders From ASH
- Immunotherapy in the Treatment of Prostate Cancer
Recently Updated
- FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for HER2-Positive Gastric Adenocarcinomas
- Breast, Cervical, CRC Screening Below Healthy People 2020 Targets
- Overall Cancer Death Rates Decreased From 1991 to 2018
- Long-Term Outcomes With Frontline Nilotinib vs Imatinib in Newly Diagnosed CML in Chronic Phase
- Melflufen Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma